Overview

A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery

Status:
COMPLETED
Trial end date:
2023-12-14
Target enrollment:
Participant gender:
Summary
This is a prospective, real-world study aimed to evaluate the efficacy and safety of Dexycu in treating postoperative inflammation of cataracts.
Phase:
PHASE4
Details
Lead Sponsor:
Ocumension Therapeutics (Shanghai) Co., Ltd
Treatments:
Calcium Dobesilate